Chandra Bhagat Pharma opened lower at -, compared with its previous close of ₹57.85. In the last trading session on 12 Nov 2026, the stock traded between - and -, with an average traded price of -. It showed a sideways intraday trend.
An investment of ₹10,000 made 5 years ago in Chandra Bhagat Pharma is now worth
₹ 8,286.00
Resulting in a loss of
₹ 1,714.00 (17.14%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
+0.00 (+0.00%)
Day High
-
Day Low
-
Day Open
-
Prev Close
₹57.85
Volume
-
Value Traded
-
1W Return
1.05%
1M Return
51.44%
3M Return
21.00%
6M Return
75.63%
1Y Return
38.72%
Market Cap (₹ Cr.)
44
PE Ratio
14.30
PB Ratio
1.32
Dividend Yield
-
ROE
9.20%
ROCE
17.10%
Book Value (₹)
43.90
Face Value (₹)
10.00
EPS (TTM)
-
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
1.05%
6 Weeks
-
1 Month
51.44%
3 Months
21.00%
9 Months
37.44%
No data available.
Chandra Bhagat Pharma: Non-promoters acquire 8 lakh warrants each
Promoter group acquired 50 lakh warrants, raising diluted stake to 74.29%. Non-promoters Samir Ramkant Dave and Chintan Vijay Makhecha acquired 8 lakh warrants each. Both non-promoters now hold 5.66% diluted stake in the company. Total diluted share capital stands at 1,41,45,056 equity shares.
16 days agoBSE grants in-principle approval for Chandra Bhagat Pharma warrant issue
BSE grants in-principle approval for 66,00,000 convertible warrants. Warrants convertible into equity shares at minimum ₹44 per share. Issue targeted at promoters and non-promoters on preferential basis. Company must ensure allottees avoid intra-day trading before allotment.
1mo agoChandra Bhagat Pharma AGM resolutions pass unanimously with 100% support
All four AGM resolutions passed unanimously with 100% support from polled votes. Promoters held 5.5 million shares (73%) and voted fully in favor. Only eight shareholders attended the physical meeting in Mumbai. Issuance of 66 lakh convertible warrants approved on preferential basis.
2mo agoChandra Bhagat Pharma issues AGM notice corrigendum for warrant issue
Chandra Bhagat Pharma Limited released a corrigendum to its AGM notice on August 20, 2026. The filing provides the web link for the compliance certificate required for the proposed preferential allotment of 66 lakh convertible warrants. The AGM is set for September 1, 2026, in Mumbai.
2mo agoChandra Bhagat Pharma seeks approval for ₹29.04 cr warrant issue
Chandra Bhagat Pharma Limited is holding its 23rd AGM on September 1, 2026, to approve a ₹29.04 crore convertible warrant issue and an increase in authorized share capital to ₹15 crore. The company reported a PAT of ₹304.61 lakh for FY26, driven by revenue growth to ₹11,627.17 lakh. Proceeds from the warrant issue will fund working capital and expansion into vaccine formulations.
3mo agoChandra Bhagat Pharma plans fund raise via preferential allotment
Chandra Bhagat Pharma Ltd convenes its Board on August 5, 2026, to approve a preferential allotment of equity shares or convertible warrants for fundraising. The agenda also includes increasing authorized share capital and scheduling an EOGM for shareholder approval. Insider trading windows remain closed until 48 hours post-meeting.
3mo ago| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹1,899.30 | +0.76% | ₹4,55,705.69 | 41.20 | +9.65% | |
| ₹11,495.00 | +0.09% | ₹3,05,156.13 | 90.40 | +76.30% | |
| ₹4,685.20 | -0.89% | ₹1,78,209.95 | 85.50 | +22.50% | |
| ₹2,427.00 | +1.13% | ₹1,31,133.78 | 97.10 | +145.34% | |
| ₹1,204.50 | -0.12% | ₹1,20,149.34 | 28.00 | +26.60% | |
| ₹1,388.30 | +0.12% | ₹1,15,878.66 | 42.00 | +12.91% | |
| ₹1,409.80 | +0.11% | ₹1,13,891.88 | 39.90 | -7.21% | |
| ₹2,663.30 | +0.94% | ₹1,10,006.30 | 48.10 | +17.33% | |
| ₹1,808.90 | +0.09% | ₹1,04,080.11 | 26.00 | +52.83% | |
| ₹2,019.10 | +0.20% | ₹92,331.42 | 17.60 | -0.73% | |
| ₹2,639.00 | -0.78% | ₹74,479.09 | 51.60 | +42.82% | |
| ₹5,194.00 | -2.04% | ₹62,102.06 | 30.50 | -9.94% |
An investment of ₹10,000 made 5 years ago in Chandra Bhagat Pharma is now worth
₹ 8,286.00
Resulting in a loss of
₹ 1,714.00 (17.14%)
Note: Past profits do not guarantee future returns.
